✦ LIBER ✦
A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: Preliminary safety and immunogenicity
✍ Scribed by Liao, J.B.; Cecil, D.L.; Reichow, J.; Parker, S.; Higgins, D.; Childs, J.; Broussard, E.; Coveler, A.; Salazar, L.; Disis, M.L.
- Book ID
- 127359775
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 47 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.